Project objectivesMulticenter randomized phase III study with second-line chemotherapy combined or not with bevacizumab in patients with stage III-IV ovarian cancer with platinum-sensitive disease pretreated with bevacizumab. |
Start and end date |
| 2014 - 2018 |
Project Manager |
| Prof. Angioli Roberto - Coordinator |
Coordinating institution of the project |
| UCBM |
Go back
About Us
Admissions
Study with us
International
Third Mission
Research
Services
- Mission and History
- Statute and Regulations
- Promoters and Supporters
- Biomedical University Foundation
- Governance
- Whistleblowing
- Student Representatives
- Opus Dei
- Visit the Campus
- Competitions
- Group I and II professors - Evaluation Procedures
- Group I and II professors - Selection Procedures
- Researchers
- Contract Teachers
- Research fellows
- Digital
- Public tenders
- Study with us
- Master's Degree Courses
- Master's Degree Courses
- Specialization Schools
- PhD
- UCBM Academy
- Bootcamp 2025
- Foundation Year
- ACADEMIC CALENDAR
- Educational Organization
- Academic Council
- Academic team
- Faculty Department of Medicine and Surgery
- Faculty Dept. of Engineering
- Faculty Dept. of Science and Technology for Sustainable Development and One Health
International
A network of international, scientific and educational relations to encourage mobility.
Visit the section
- Student services
- Orientation
- Career Service
- Internships in the healthcare sector
- International
- Scholarships
- Support
- Student accommodation
- Tutoring
- Counseling
- Library
- Catering
- Commercial Agreements
